{"changeSha256":"4925469615cd632a85b1c0cf4add765550e08cb064a483084c49bf6869f56274","changedAt":"2026-11-15","changedFields":[{"after":"PeptideScanner retained ClinicalTrials.gov record NCT07481734 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tesamorelin.","before":"PeptideScanner retained ClinicalTrials.gov record NCT07481734 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-19, and PeptideScanner's reviewed identity mapping was tesamorelin.","field":"Summary"},{"after":"2026-11-12","before":"2026-03-19","field":"Cited source date"},{"after":"2026-11-15","before":"2026-07-30","field":"Source observed date"},{"after":"ctg-observation-nct07481734-2026-03-19-79e26d9bce31-r2","before":"ctg-observation-nct07481734-2026-03-19-79e26d9bce31","field":"Cited source records"},{"after":"ctg-observation-nct07481734-2026-03-19-79e26d9bce31-r2","before":"ctg-observation-nct07481734-2026-03-19-79e26d9bce31","field":"Headline citations"},{"after":"ctg-observation-nct07481734-2026-03-19-79e26d9bce31-r2","before":"ctg-observation-nct07481734-2026-03-19-79e26d9bce31","field":"Summary citations"},{"after":"1. PeptideScanner retained ClinicalTrials.gov record NCT07481734 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tesamorelin. [sources: ctg-observation-nct07481734-2026-03-19-79e26d9bce31-r2]\n2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct07481734-2026-03-19-79e26d9bce31-r2]","before":"1. PeptideScanner retained ClinicalTrials.gov record NCT07481734 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-19, and PeptideScanner's reviewed identity mapping was tesamorelin. [sources: ctg-observation-nct07481734-2026-03-19-79e26d9bce31]\n2. This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. [sources: ctg-observation-nct07481734-2026-03-19-79e26d9bce31]","field":"Attributable context"},{"after":"4db6e7df5bfe3f74593f4acab120fc16eae461271e7bd5c4ae9e1a305979d20d","before":"71841b0389a60f9ef68bd50fb31e7127ae4fa8dd080a1e8c83ffdbfea0383622","field":"Source snapshot commitment"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07481734-tesamorelin/#version-2","version":2},"id":"story:clinicaltrials-gov-nct07481734-tesamorelin:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"record-updated","notice":"ClinicalTrials.gov posted a newer version of NCT07481734, with a registry update date of 2026-11-12. This version reports that observation; the earlier retained observation remains available as version 1.","peptideSlugs":["tesamorelin"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07481734-tesamorelin/#version-1","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"ctg-observation-nct07481734-2026-03-19-79e26d9bce31-r2","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07481734 · retained source version 2026-11-12:944f22a8653ce80e071c725e8e3cce5485f2a68ffd25ad5ecc2e9db3e763fea4","url":"https://clinicaltrials.gov/study/NCT07481734","verifiedAt":"2026-11-15"}],"subject":{"slug":"clinicaltrials-gov-nct07481734-tesamorelin","type":"story"}}
